PosterSessionOnline

WORLD FEDERATION OF HEMOPHILIA

WFH 2026 World Congress

April 19-22, 2026 Kuala Lumpur

N. Poster

Poster title

Applicant name

Status


MP-2	VGA039, a protein S-targeted monoclonal antibody, promotes in-vitro thrombin generation in plasma samples from subjects across a broad range of bleeding disorders, including von Willebrand disease, Hemophilia A, Hemophilia B and Hemophilia C	Kristen Jaworski	Received

PP-003	Elucidating Pseudotumor Pathogenesis in Coagulation Disorders Through Combined Clinico-pathological and Genomic Approaches	Mariya Tomy	Received

PP-004	Von Willebrand Disease in Tunisia: Insights from a 39-Year Bicentric Cohort	Meriem Achour	Received

PP-007	Analysis of aPTT-Based Clot Reaction Curve in Patients With Haemophilia A, Acquired Haemophilia A and Lupus Anticoagulant – a Single Tertiary Hospital Experience	Lean Theng Ewe	Received

PP-8	The Spectrum of the Factor 8 (f8) Defects in 106 Children with Haemophilia A (HA) living in Greece: a Single Centre Experience	Athina Dettoraki	Received

PP-010	The Hematocrit Factor: Adjusting anticoagulants for accurate coagulation analysis	Maliha Sumbul	Received

PP-012	Acquired Hemophilia A: Monocentric Experience of a Tunisian Center	Ghassen Saidi	Received

PO-014	Effects of human placenta hydrolysate and thymosin alpha 1 on blood coagulation parameters in patients with hemophilia A: An ex vivo study	Ki Young Yoo	Received

MP-016	The DivulgHEMOs Project: Advancing Hemophilia Literacy for Laypeople, Patients, and Their Families Through Social Media	Ricardo Mesquita Camelo	Received

MP-17	Capacity building of patients to report their bleeds & treatment data through myWBDR	Hamza Qureshi	Received

PP-018	The World Federation of Hemophilia Strategic Plan 2026–2030	Alain Baumann	Received

PP-019	Turning Data Into Voice: Regional Advocacy Priorities for Bleeding Disorders in the Eastern Mediterranean Region	Donna Coffin	Received

PP-022	Evaluating the Impact of WFH Programs on Clinical & Health Care Outcomes in Pakistan: A Case Study	Donna Coffin	Received

PO-024	From Vision to Action: National Bleeding Disorders Foundation´s Roadmap for Achieving Health Equity, Diversity, and Inclusion	LEONARD VALENTINO	Received

PP-025	Building Organizational Resilience to Serve Bleeding Disorder Communities	Deon York	Received

PP-27	Digital Advocacy, Legal Literacy, and Holistic Wellness: An African Hemophilia Youth Multi-Pillar Empowerment Model for Health Equity.	Pius opalakadi	Received

MP-028	Structuring and Directing a Campaign for the Incorporation of Emicizumab for Children with Hemophilia A in Brazil	Mariana Battazza	Received

PP-029	Establishing a National Hemophilia Helpline to Strengthen Information Access and Community Support in Pakistan	Masood Fareed Malik	Received

PP-030	Developing a Psychosocial Toolkit for People Living with Bleeding Disorder in India.	Richa Mohan	Received

PP-34	Fifty years of the Catalan Hemophilia Association: from advocacy to a comprehensive model of hemophilia care and psychosocial support	Patricia Cabré	Received

FP-034	The body speaks before the child: Subjective constitution in children with hemophilia	Veronica Cerutti	Received

PP-035	Development of a therapeutic education program on heavy menstrual bleedings (HMB) across all type of congenital bleeding disorders	Caroline ARTU DUMONT	Received

PP-038	HTC Achievements	Ghazala Manzoor	Received

PP-039	Experience and Challenges in Establishing a Community-Based NGO for Hemophilia Support in Pakistan	Muhammad Amar Muhammad Amar	Received

PO-041	Empowering Bleeding Disorder in Balochistan Advocacy, Awareness and Treatment Access	Ghazala Manzoor	Received

PO-043	Promoting Transparent Practices in the World Federation of Hemophilia´s Humanitarian Aid Program	Masood Fareed Malik	Received

PO-044	Strengthening Community Capacity Through Youth-Led Volunteer Activities: A Case Study from Korea	Kanghoon Jeong	Received

PO-045	Establishing the First Public-Sector Hemophilia Treatment Centre in Pakistan: A Model for Sustainable, Comprehensive Care	Masood Fareed Malik	Received

PO-047	Improving Rural Outreach and Access to Care for People with Bleeding Disorders in Pakistan: Lessons from a Community-Based Initiative	Muhammad Amar Muhammad Amar	Received

PO-049	Educational information for professionals at health, people with hemophilia and primary caregivers.	Laura Irene Páez Briseño	Received

PO-050	Empowering Patients Through Awareness and Education in Bleeding Disorders: A Community-Led Approach from Pakistan	Muhammad Amar Muhammad Amar	Received

PO-052	A STRUCTURED PATHWAY TO SUPPORT PATIENT-HEALTHCARE PROFESSIONAL PARTNERSHIP IN THERAPEUTIC PATIENT EDUCATION FOR RARE BLEEDING DISORDERS	Caroline ARTU DUMONT	Received

PO-053	Navigating Youth Inclusion Within the Board Committee of the Hemophilia Society of Malaysia	Amierul Hakimie Luqman bin Yusli	Received

MP-054	Assessment of Comprehensive Care for Bleeding Disorders: Insights from 10 years of Annual Global Survey data	Ellia Tootoonchian	Received

MP-055	Advancing Shared Decision-Making in Hemophilia: Development and Contextualization of Consensus-Based Best Practice Statements	Donna Coffin	Received

MP-058	Improving Care for Hemophilia and Other Bleeding Disorders Through Comprehensive Clinics: Perspectives from a Low-Resource Set-Up	ALEX GACHOYA	Received

PP-059	Patient-centred Summary: Evaluating Outcomes and Follow-up Across All Severities of Haemophilia	Liz Beatty	Received

PP-060	Addressing Stigma in Hemophilia Management: Insights from Two Tertiary Hospitals in a Low-Income Country	Abu Yousuf Md Nazim Uddin	Received

PP-062	Synergies for Patients: A Domiciliary Delivery Program of Coagulation Factors for Hemophilia Patients in a Middle-Income Country´s Social Security Health System	Marilyn Mendoza	Received

MP-63	Obstacles and Limitations of Care in Adolescents and Young Adults with Hemophilia	Nongnuch Sirachainan	Received

PP-064	Humanitarian Support of the World Federation of Hemophilia: Advancing Care and Quality of Life for Individuals with Bleeding Disorders in Pakistan	Masood Fareed Malik	Received

PP-065	Navigating the Transfer of Care in Rare Bleeding Disorders: Experiences and Needs from Adolescents and Young Adults, their Caregivers and Healthcare Providers	Greta Mulders	Received

PP-066	From Regional Hospitals to Local Pharmacies: Evaluating Ten Years of Changes in Coagulation Factor Delivery in Estonia	Martin Kaal	Received

PP-067	Clinical Impact of Immediate Versus Delayed Factor Replacement in the Management of Hemophilic Bleeding Episode	Usama Grewal	Received

PP-068	Plain Language Summary: What is Extravascular Distribution of Factor IX and how does it Affect Management of Those with Haemophilia B?	Liz Beatty	Received

PP-69	Evaluating The Effectiveness Of The Self-Bat screening Tool In Improving Early Diagnosis In A Tertiary Hospital	Abu Yousuf Md Nazim Uddin	Received

PP-071	Tattoos: A global bleeding disorders survey	Cathy Harrison	Received

PO-077	Advancing Evidence-Based Care: 2025–2026 Update of the WFH Living Guidelines for the Management of Hemophilia, Prophylaxis and Hemostatic Agents	Donna Coffin	Received

PO-80	Mild Matters: A Survey of US Hematologists on the Diagnosis and Management of Individuals with Mild Hemophilia	Ming Yeong Lim	Received

PO-082	Improving Diagnosis of Hemophilia by Use of Pedigree and Contact Tracing in Western Kenya	Nancy Midiwo	Received

PO-083	Mindset and attitudes towards people with hemophilia A after the introduction of emicizumab prophylaxis: impressions of the biopsychosocial support team	Ricardo Mesquita Camelo	Received

PP-084	Results from the IMPROVE project: Complex Co-inheritance of VWD Type 2N, VWD Type 1, and Mild Haemophilia A in a Large Multigenerational Family – Diagnostic and Therapeutic Implications	Anna Pavlova	Received

PP-085	Sixth Interim Analysis of the HEM-POWR Study: Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Patients With Severe and Nonsevere Hemophilia A	Amanda Ward	Received

PP-086	Sixth Interim Analysis of the Real-World HEM-POWR Study: Surgical Hemostasis With Damoctocog Alfa Pegol in Patients With Hemophilia A	Amanda Ward	Received

PP-087	Galician multicenter clinical experience with emicizumab in patients with severe hemophilia a: a real-world analysis	Rebeca Guzmán	Received

PP-088	Replacement Therapy Around Percutaneous Coronary Intervention and the Subsequent Dual Aantiplatelet Therapy Period in Hepatitis C Virus and Human Immunodeficiency Virus coinfected Hemophiliacs	Haruka Uemura	Received

PP-090	Bridging the Gap: A Systematic Review of Modern Hemophilia Therapies and Global Inequities in Clinical Trial Participation	Nadiya Nurul Afifah	Received

PO-092	Bleeding Complications Following Wisdom Tooth Removal for Patients with Haemophilia and von Willebrand Disease Managed Using a Tranexamic Acid Protocol	Mathew Lim	Received

PP-093	Emicizumab Prophylaxis in Children with Hemophilia A without Inhibitors: the Brazilian Experience	Ricardo Mesquita Camelo	Received

PP-095	Real-World Effectiveness, Safety, and Quality-of-Life Outcomes of Lonoctocog Alfa in Thai Paediatric Previously Treated Patients with Severe Haemophilia A: A Case Series	Nongnuch Sirachainan	Received

PO-096	Physical Activity and Bleed Prevention for People With Severe Haemophilia A Treated With Once-Weekly Efanesoctocog Alfa: A Plain-Language Summary of 12-Month Interim Results From the FREEDOM Study	Nadia Gonnermann	Received

PO-97	Exploratory Analysis from HAVEN 1–4 to Further Contextualise Injection-Site Reactions Among People with Haemophilia A Receiving Emicizumab	Helen Miller	Received

PO-098	Bringing American Thrombosis and Hemostasis Network (ATHN) Research Opportunities to Patient-Facing Conferences: The One Drop Experience	Shelby Domino	Received

PO-099	Adult and adolescent hemophilia patients treated with MarstacimaB: a patient Experience Registry (AMBER) and Real-World Assessment of Treatment Burden and Patient Preferences	Mankai Ju	Received

PP-102	Therapy Adjustment in Patients with Coagulation Disorders and Myeloproliferative Neoplasms	Maria Teresa Alvarez Roman	Received

PP-104	Prevalence of Overweight and Obesity in Hemophilia: Evidence From a Real-World Cohort in Córdoba	Monica Martinez	Received

PO-106	BODY MASS INDEX (BMI) IN TUNISIAN PATIENTS WITH HEMOPHILIA: INSIGHTS FROM THE World Bleeding Disorder Registry (WBDR)	Ons Ghali	Received

MP-107	The WFH Gene Therapy Registry: Early Implementation Experience and Global Collaboration	Mayss Naccache	Received

PP-108	Universal Clinical Intelligence & Psychosocial Network: A Scalable Generalist Digital Health Ecosystem for Complex Chronic Disease Management	Ronald Mahomane	Received

PP-109	Impact of the Socioeconomic Status of the Patient on the Management of Hemophilia A	Usama Grewal	Received

PP-110	Public Assistance for People with Hemophilia in Brazil (PATCH) Survey: Outcome Assessment across the Brazilian Hemophilia Treatment Centers	Ricardo Mesquita Camelo	Received

PP-111	Management of hemophilia in developping countriesThe Moroccan experience	Mohamed El khorassani	Received

PP-112	Development of a National Web-Based Patient Registry as a Tool for Strengthening Care, Data Quality, and Health Advocacy in Pakistan	Masood Fareed Malik	Received

PP-113	Breakthrough Bleeds Among People With Severe Hemophilia on Prophylaxis Therapy at a Tertiary Centre	Suhaila Sukiman	Received

PP-114	Growth in use of myWBDR in Tunisia	Kaouther Zahra	Received

PP-116	USE OF WBDR MONITORING HJHS FOR PATIENTS WITH HEMOPHILIA	Kaouther Zahra	Received

PO-117	Public Assistance for People with Hemophilia in Brazil (PATCH) Survey: Inhibitor Screening and Diagnosis, and Immune Tolerance Induction	Ricardo Mesquita Camelo	Received

PO-118	Public Assistance for People with Hemophilia in Brazil (PATCH) Survey: Patient Profiles, Interdisciplinary Team, and Treatment Support across the Brazilian Hemophilia Treatment Centers	Ricardo Mesquita Camelo	Received

PO-120	Hemophilia Patient Journey study in China	Linguo Li	Received

PP-125	Understanding Gene Editing in Hemophilia: A New WFH Education Initiative	Mayss Naccache	Received

MP-128	The Iron Triangle of Cure: A Quantitative Risk Framework (PD, LGD, CVaR) for Securitizing Gene Therapy Supply Chains in Emerging Markets	Ronald Mahomane	Received

PP-129	Actual Impact of Overweight and Obesity on Coagulation Factor Consumption and Healthcare Costs in Patients with Haemophilia	Hossein Motahari	Received

PP-130	DivulgHEMOs Project: An Educational Initiative to Improve Hemophilia Knowledge in Infrequent Healthcare Providers	Ricardo Mesquita Camelo	Received

PP-133	Establishment of Hemophilia Welfare Society Balochistan	Ghazala Manzoor	Received

PP-135	The Holistic Health Potential Metric: A Novel Composite Measure Integrating Biomedical, Social, and Systemic Determinants	Ronald Mahomane	Received

MP-137	Changes in hypertrophic synovium status in adult patients with severe HA receiving emicizumab prophylaxis	Ilenia Calcaterra	Received

MP-138	Research and Single–Center Validation of a Convolutional Neural Network–Based Ultrasound Assessment Model for Hemophilic Arthropathy	Jun Li	Received

PP-140	Comparison of Point-of-Care Ultrasonography (POCUS) With Magnetic Resonance Imaging (MRI) in Assessment of Joints in Hemophilic Arthropathy	Praveen Kumar	Received

PP-141	Protecting Joints from the Start: Point-of-Care Ultrasound Evidence Supporting Primary Prophylaxis in Hemophilia	Mauro Dyntino	Received

PP-142	Comprehensive musculoskeletal evaluation in hemophilia: Relationship between arthropathy and tendinopathy using HEAD-US and THD-US methods	ALVARO AUGUSTO VARGAS CARO	Received

PP-143	Musculoskeletal Ultrasound for Joint Monitoring in Patients with Hemophilia: a Longitudinal Study	Henry Hon Wai Lam	Received

PO-147	Spontaneous Retroperitoneal And Psoas Muscle Hematoma, With Abscess And Calcification, In Severe Hemophilia A: Challenges In The Context Of Limited Resources	Etelvina de Jesus Elija	Received

MP-148	Diverse B-cell Responses to FVIII in Persons with Severe Hemophilia A	SHANNON MEEKS	Received

PP-150	Inhibitors in Haemophilia A & B: UK Lived Experiences Across Life Stages	Ranjit Nagra	Received

PP-153	Genetic and Clinical Characteristics of Haemophilia A Patients with Factor VIII Inhibitors	Kee Tat Lee	Received

PP-154	Clinical Characteristics of Factor VIII Inhibitor Development in Children with Hemophilia A in Indonesia: Experience from a Low- and Middle-Income Country	Purnamasari Natsir Putri	Received

PP-155	Drastic Bleed Reduction With Adjunctive Emicizumab in Immune Tolerance Induction-Refractory Haemophilia A and High-Risk Genetics: A Clinical Management Strategy	Wan Alia Amalina Binti Adenan	Received

PP-156	Factor VIII inhibitor detection by bovine based chromogenic Nijmegan- Bethesda assay – Experience from a Specialised Coagulation Laboratory	Sitalakshmi Subramanian	Received

PP-157	Spectrum of F8 Gene Variants in Haemophilia A Patients With Inhibitor Development	Nursaedah Abdullah Aziz	Received

PP-158	Prevalence of Inhibitor Development in Malagasy Patients with Hemophilia: A Prospective Study	Toong Youttananukorn	Received

PP-159	Modifiable and non-modifiable risk factors for inhibitor development in previously untreated patients with haemophilia A controlled in Venezuela National Hemophilia Center	Apsara Boadas	Received

PO-161	Acute Compartment Syndrome in a Haemophilia A Patient With Inhibitors: A Case Report	Marwa N. Soramairy	Received

PO-162	Hemophilia A Inhibitors in Sousse, Tunisia: First Local Insights, Diagnostic Barriers, and Management Outcomes	Ghassen Saidi	Received

PO-163	Inhibitor testing in Hemophilia our experience at HTC from a govt. facility in North India	Savitri Singh	Received

PO-164	Organized Gluteal Hematoma in Hemophilia A Patient with Factor VIII Inhibitors Treated with On-Demand Therapy	Salih Aksu	Received

PO-165	Inhibitors in Hemophilia: A Challenging Complication	Maha charfi	Received

MP-168	Utilising Thromboelastography for Predicting Bleed Risk in Patients with Mild Haemophilia A and Factor VIII Discrepant Assays	Stephanie Wong	Received

MP-169	Long-Term Evaluation of External Quality Assessment Results for Factor VIII	Claudia van Rijn	Received

MP-170	Bridging the Assay Gap: One more reagent for Accurate Measurement of Efanesoctocog Alfa	Angelo Claudio Molinari	Received

PP-171	Long-term performance of Factor VIII inhibitor testing by laboratories participating in the ECAT External Quality Assessment Programme	Piet Meijer	Received

PP-172	Long-Term Performance of Factor VIII by Laboratories of the Italian Haemophilia Centers.	Claudia van Rijn	Received

PP-173	Strategies to correct FVIII interference on emicizumab plasma levels	RODOLFO SUELDO	Received

PP-174	Long-term performance of Factor VIII inhibitor testing by laboratories of Italian Hemophilia Centers	Piet Meijer	Received

PP-176	Performance Evaluation of a One-Stage Clotting Assay for Monitoring Efanesoctocog Alfa Activity: Insights from the ECAT 2024 Survey	Marika Pikta	Received

PP-177	Improving Hematology Lab Results: Detecting Preanalytical Errors through Quality Metrics	Noorulain Fareed	Received

PP-180	Challenges in Laboratory Assessment of Hemophilia A Patients on Emicizumab Undergoing Surgery: A Single-Center Experience from South India	Bitty Kurian	Received

PP-181	Critical Value Matters: A Study of Critical Value Identification and Notification to clinicians in the hematology section of the Pathology Laboratory at a Tertiary Care Hospital	Noorulain Fareed	Received

PP-182	Molecular Diagnosis of Unresolved Congenital Coagulopathies: Beyond Routine Testing	Francisco Vidal	Received

PO-184	Efanesoctocog alfa Measurement Using Reagent Substitutions and Determining its In Vitro Temperature Stability	Geoffrey Kershaw	Received

PP-185	Transferrin Receptor 1 as a Novel Therapeutic Target for Hemophilic Synovitis	Tsunemasa Kita	Received

MP-186	FVIII Expression Via Non-viral Vector DNA Medicine Platform Results in Efficacious Levels of FVIII Protein and Correction of the Bleeding Phenotype in Hemophilia A Mice	Stefani Slog	Received

PP-189	Thrombotic Events in Adult Patients With Severe Hemophilia on Emicizumab: Results of a National Study	Predrag Miljic	Received

PP-190	Real-World Effectiveness and Safety of Emicizumab in a Cohort of 39 Pediatric Patients with Hemophilia A in Balochistan, Pakistan	Mohammad Qayyam Khan	Received

PP-192	Advocacy on the Impact of Emicizumab on Young Lives in Mauritius	Janaki Sonoo	Received

PP-193	THE ROLE OF EMICIZUMAB IN HEMOPHILIA PATIENTS WITH ANTI-FVIII INHIBITORS A REPORT OF 5 CASES :	Mohamed El khorassani	Received

MP-195	Nursing Practice in the Era of Emicizumab: Five-Year Surgical Experience at the Queensland Haemophilia Centre	Alexandra Klever	Received

PP-196	Challenges in Maintaining Employment for Hemophilia Survivors in Their forties Infected with HIV Through Blood Products and Implications for Nursing Support	Miwa Ogane	Received

PP-198	Oral hygiene habits, sugar consumption, and dental care in children with hemostasis disorders	Laura Beatriz Isidro-Olán	Received

PO-199	Evaluation of underlying etiology and therapeutic challenges of Recurrent Gingival Hemorrhage in Severe Hemophilia A: A Case Report from a Developing Country	Salsa Makruf	Received

MP-200	Standard Half-Life (SHL) and Extended Half-Life (EHL) FVIII in Major Orthopedic Surgery: Evidence from Real-World Experience.	ezio.zanon@unipd.it ezio.zanon@unipd.it	Received

PP-201	Awareness of Hemophilic Patients Regarding Potential Orthopedic Abnormalities of Target Joints	Usama Grewal	Received

PP-203	Myositis Ossificans as a Complication of Haemophilia: A 20-year retrospective case series	Adam Hussain	Received

PP-204	Correlation of FVIII:C and Joint Health in Korean Patients with Hemophilia A	Hong Hoe Koo	Received

PP-205	Pediatric Severe Hemophilia with Ankle Hemophilic Arthropathy: Microfracture with Cartilage Repair- Surgical Case Study	Elia Fong	Received

PP-206	Orthopaedic Management of Complex Haemophilic Arthropathy of the Ankle Joint	Adam Hussain	Received

PP-207	Managing Complex Haemophilia A Presentations in Low-Resource Settings: A Two-Case Series Highlighting Multisystem Challenges and Delayed Access to Therapy	Erick Ayaye	Received

PO-208	Prophylaxis vs On-Demand Treatment: Ripple Effects After Many Years!	Waleed Grewal	Received

PO-209	A proposed classification for end stage hemophilic knee arthritis requiring Total knee replacement with suggested treatment/ constraint options.	Sandeep Albert	Received

PO-210	Management of Hemophiliac Arthritis of Target Joints	Usama Grewal	Received

PO-211	Establishing a Multidisciplinary Model for Musculoskeletal Surgery in Severe Hemophilia within a Resource-Limited Setting	Bhaskar Pant	Received

PO-213	A retrospective study of Radiosynovectomy on Target Joints in Haemophilia from a Tertiary Hospital	Shin Yen Yeam	Received

PO-214	Surgical Outcomes in Extremity Hemophilic Pseudotumors	Sanjana Bose	Received

PP-215	Determinants of Central Sensitization in Hemophilic Arthropathy: A Multicentre Analysis of Psychosocial and Joint-Related Predictors.	Ruben Cuesta-Barriuso	Received

PP-216	Effectiveness and Tolerability of a Topical Emulgel Containing Glucosamine Sulphate, Chondroitin Sulphate, Curcumin, Boswellia Serrata, Ginger, Oil of Wintergreen, and Menthol in Pediatric Haemophilic Arthropathy	Pamela Narayan	Received

MP-218	Long-Term Outcomes and Inhibitor Relapse Following Immune Tolerance Induction in Severe Hemophilia A Children with Inhibitors: A Prospective Multicenter Study	Runhui Wu	Received

PP-219	The Hemophilia Health Journey: Exploring the Experiences and Unmet Care Needs of Young Children with Hemophilia and their Caregivers	Caroline Mussert	Received

PP-220	A Single Paediatric Centre Experience in Immune Tolerisation Induction (ITI) for Paediatric Severe Haemophilia A Patients with Inhibitors on Subcutaneous Emicizumab	Chiew Ying Lim	Received

PP-221	Clinical Profile of Children with Factor XI Deficiency in Singapore	Nur Insyirah Abdul Kadir	Received

PP-222	Pharmacokinetic Parameters Related Bleeding Outcomes of Hemophilia A Treated with Low Dose Prophylaxis Treatment in Thailand Under National Health Security Office Scheme in Thailand	Bunchoo Pongtanakul	Received

PP-223	Novel Variants in Hemophilia A Patients: Report from a Referral Hemophilia Treatment Centre in Indonesia	Fitri Primacakti	Received

PP-225	Clinical Profile of Hemophilia Children Admitted to a Limited-Resource Hospital in West Nusa Tenggara, Indonesia: A Cross-Sectional Study	Yudhi Kurniawan	Received

PP-226	Recurrent Hemophilic Pseudotumor in Mild Hemophilia A with Neurofibromatosis Type 1: Experience from a Low- and Middle-Income Country	Purnamasari Natsir Putri	Received

PP-227	Paediatric Haemophilia B in Northern Peninsular Malaysia: A Descriptive Analysis of Patient Profiles and Outcomes	Chee Enn Han	Received

PP-228	Safe Childhood: Helping Children With Hemophilia A Stay Active and Confident	Aamir Aslam Awan	Received

PP-229	Epidural Hematoma on the Left Frontoparietotemporal Region in a Child with Newly Diagnosed Severe Hemophilia A: A Case Report	Salsa Makruf	Received

MP-232	Efficacy and Safety of Low-Load Blood Flow Restriction Training in Hemophilic Ankle Arthropathy: A Multicenter Randomized Clinical Trial	Rubén Cuesta-Barriuso	Received

PP-233	Recreative Sport, Joint Health, and Musculoskeletal Power in Children and Young People with Haemophilia	Carlos Cruz-Montecinos	Received

PP-235	Ten Years of Multidisciplinary Rehabilitation Check-ups for People with Hemophilia in Japan: Long-Term Survivors of HIV Acquired from Historically Contaminated Blood Products	Fujitani Junko	Received

PP-236	A comparison of patients presenting with musculoskeletal issues to the bleeding disorder rheumatology clinic 10 years apart	Abi Polus	Received

PP-237	The Effects of Physical & Mental Health Rehabilitation Program(PMHRP) in post operative periods for hemophilic arthritis	Won-Sook Bak	Received

PP-238	A Prospective Ultrasound Framework for Physiotherapists Working in Haemophilia Care	James Cartwright	Received

PP-241	Safety and Efficacy of Physiotherapy in Patients with Severe Hemophilia A Treated with Emicizumab: A Prospective Polish Multicenter Study	Ewa Stefanska-Windyga	Received

PO-243	Role of Physiotherapy to Rehabilitate a Person with Hemophilia Induced Foot Drop: A Case Study	Easmin Ara Doly	Received

PO-246	Individualized Physiotherapy Program Combining Manual Therapy and Exercise Improves Musculoskeletal System, Cardiopulmonary Endurance and Quality of Life in Patients With Hemophilia A	Wan-Jung Kao	Received

PO-247	Neuromotor Reprogramming in Hemophilia: Preliminary Experience Using the Allyane Method	Mauro Dyntino	Received

PO-248	Point of Care Ultrasound Use Among Australian Physiotherapists Working with People with Bleeding Disorders	Abi Polus	Received

MP-249	Long-term outcome with emicizumab prophylaxis for haemophilia A in China and efficacy prediction using machine learning	Yuan Xu	Received

MP-250	Efficacy of Low-Dose Emicizumab Prophylaxis in Hemophilia A: A Systematic Review and Meta-Analysis	April Joy Ong	Received

PP-251	Real-World Efficiency of EHL FIX Prophylaxis in Hemophilia B	Olga Benítez Hidalgo	Received

PP-253	Real-World Experience with Emicizumab Prophylaxis from a single Canadian Tertiary Care Center	Areeb Hassan	Received

PP-255	Pediatric Cohort Treated With rIX-FP (Idelvion): Real-World Analysis of Efficacy, Safety, PK Improvement and Resource Utilization	BOLIVAR LUIS DIAZ JORDAN	Received

PP-256	The Role of Low dose Emicizumab Prophylaxis in Improving PedHAL Domains and Clinical Outcomes in Children with Hemophilia: An insight from a low-middle income country.	Shigy Francis	Received

PP-257	Level of Knowledge of Hemophilia Patient´s Families in Implementing Prophylactic Therapy at the Hemophilia Treatment Center Ulin General Hospital , Banjarmasin, Indonesia	Wulandewi Marhaeni	Received

PP-259	Determinants of Adherence to Clotting Factor Prophylaxis in Adolescent and Adult Men with Hemophilia	Alice Sacramento	Received

PP-261	Management for Hemophilia A Pediatric Patients without Inhibitors Receiving Nationwide Emicizumab Prophylaxis	sanikarn nakrong	Received

PP-262	New Confidence Through Modern Prophylaxis: Community Experiences With Emicizumab in Hemophilia A	Aamir Aslam Awan	Received

PP-263	Bleeding Outcomes >3 Years After Discontinuing Emicizumab Among Persons With Hemophilia A in a Low-Resource Setting: Experience From Moi Teaching and Referral Hospital, Kenya	Everlyn Aliwa	Received

MP-267	"Hemophilia explained for children": A psychosocial approach through storytelling	Patricia Cabré	Received

MP-268	Tea Party Care in the Hemophilia Community: A Psychosocial Healing Program for Parents of Children with Hemophilia	Jeong Sik Hwang	Received

MP-269	Patient-Reported Outcomes on Artificial Intelligence Use in Hemophilia: a Psychometric Evaluation	Cindy Komar	Received

PP-271	Mental Health Needs Assessment Among People With Hemophilia in Nepal: A Mixed- Methods Study	Toong Youttananukorn	Received

PP-272	Evaluating the World Federation of Hemophilia´s Shared Decision-Making Tool: Insights from a Multi-Group Impact Study	Donna Coffin	Received

PP-273	Emotional Burden and Marginalization in Individuals with Bleeding Disorders	Midhat Khalid	Received

PP-275	The Importance of the Psychosocial Approach in the Healthcare Team: Current Reality and Future Perspectives	Silvina Grana	Received

PP-276	Advancing Mental Health and Substance Use Care Accessibility for Individuals With Bleeding Disorders: A United States Multi-State Outreach and Champion Facility Identification Model	Shanthi Hegde	Received

PP-278	Navigating Life With Bleeding Disorders: Understanding the Lived Psychosocial Experiences of Youth	Midhat Khalid	Received

PP-280	Psychosocial well being and exercise participation of patients with Haemophilia and the carers in Hong Kong	Henry Hon-Wai Lam	Received

PP-281	Feasibility and Engagement of an Online CBT-Based Group Intervention for Adolescents with Haemophilia	Anna-Maria Tsilia	Received

PP-282	Emotional Impact of Hemorrhagic Disorders on Mexican Female Caregivers: Prevalence of Anxiety and Depression	Ezequiel Martinez Martinez	Received

PP-283	Neurobiological Perspectives on Hemophilia: A Review of Neurological, Cognitive, and Psychosocial Interactions	Ferose Pallimanhayalil	Received

PP-284	Beyond Carriers: Promoting Recognition, Diagnosis, and Psychosocial Inclusion for Women with Bleeding Disorders in Korea	Jeong Sik Hwang	Received

PP-287	Comparison of psycho-social difficulties faced by haemophilia patients with and without HIV/AIDS	Tomie Fujii	Received

PP-288	Creating a Children´s Book as a Tool for Education and Support	Darian Smith	Received

PP-290	Innovations in Child Life Services for Hemophilia Care in Kenya: Enhancing Psychosocial Support and Treatment Compliance for Pediatric Patients Living with Hemophilia	Bilha Nyaboke Omari	Received

PP-291	Balancing Hemophilia Care and Cultural Practices:Psychosocial and Clinical Outcomes of Circumcision with Optimized Factor Therapy	AJAI THOMAS	Received

PP-292	Ibero-American Psychosocial Group: A Collaborative Network in Development	Silvina Graña	Received

PP-295	New educational strategies for individuals with hemophilia and autism	Tongpil Min	Received

PP-296	Hemophilia and autism: where do challenges come from?	Gavin Min	Received

PP-297	A Study on Development of RAG-based Psychological Counseling Support System via Analysis of Unmet Counseling Needs in Hemophilia Patients	Jihun Chang	Received

PO-298	Bleeding in Silence: A Young Man´s Battle for Identity, Dignity, and Hope with Severe Hemophilia A	Masood Fareed Malik	Received

PO-300	Personal Coping Pathways and Psychosocial Resilience in a Person With Hemophilia	Masood Fareed Malik	Received

MP-303	Psychological Well-being in Primary Caregivers of People with Coagulopathies	Ezequiel Martinez Martinez	Received

MP-305	Patient-Reported and Clinical Outcomes in Persons with Severe Hemophilia (PwSH) Treated Within vs. External to U.S. Hemophilia Treatment Center Network Clinics: An Update from the CHESS US Study	Randall Curtis	Received

MP-306	Hemophilia Life Stages and Changes Global Survey of People with Hemophilia, Caregivers, and Hematologists: Patient Experience According to Disease Severity and Gender	Kim Isenberg	Received

MP-307	Psychological Burden and Quality of Life of Mothers of Hemophiliac Children: A study of 69 cases	Mohamed El khorassani	Received

PP-309	WBDR RSP Series Part 1/6: Beyond Patient Registry – Demonstrating Multifunctional WBDR Value Across Six Domains (32 Research Support Program Projects, 2018–2023)	Toong Youttananukorn	Received

PP-310	WBDR RSP Series Part 2/6: Generating Clinical Evidence That Informs Policy – Four Focused Research Areas from 32 RSP Projects (2018–2023)	Toong Youttananukorn	Received

MP-311	WBDR RSP Series Part 3/6: Diagnosis Evidence– Findings From Research Projects Under the WFH WBDR Research Support Program (2018–2023)	Toong Youttananukorn	Received

PP-312	WBDR RSP Series Part 4/6: Quality-of-Life Evidence – Findings From Research Projects Under the WFH WBDR Research Support Program (2018–2023)	Toong Youttananukorn	Received

PP-313	WBDR RSP Series Part 5/6: Prophylaxis Evidence - Findings From Research Projects Under the WFH WBDR Research Support Program (2018–2023)	Toong Youttananukorn	Received

PP-314	WBDR RSP Series Part 6/6: Underserved Populations (WGBD/VWD) Evidence - Findings From Research Projects Under the WFH WBDR Research Support Program (2018–2023)	Toong Youttananukorn	Received

PP-315	Insights into Physical Function and Treatment Experience with Mim8: Patient Cases from the FRONTIER Trials	Jayson Tang	Received

PP-316	Patient-Reported Outcomes in Hemophilia in Kosovo: Results from the PROBE Questionnaire	Dawn Rotellini	Received

PP-317	The Quality of Life of Hemophilia A Patients Accessing Treatment Services	Toong Youttananukorn	Received

PP-318	Long-Term Treatment Adherence Decline in Pediatric Hemophilia Patients Receiving Extended Half-Life Therapies: A Cross-Sectional Study in South Korea	Harim Kim	Received

PP-319	Assessing the Change in Bleeding Rates and Related Clinical Outcomes in Haemophilia Patients Before and After Introducing Humanitarian Aid Clotting Factor Concentrates in Malawi	Francis Mkwenembera	Received

PP-320	Real-World Effectiveness and Patient-Reported Burden of Pharmacokinetic-Guided Individualized Prophylaxis in Chinese Hemophilia A Patients	Shaoyu Yin	Received

PP-321	Health-Related Quality of Life among Adults with Haemophilia in Southern Nigeria	Toong Youttananukorn	Received

PP-322	Adapting the Patient Reported Outcomes Burdens and Experiences (PROBE) Study to Measure Quality of Life in People with von Willebrand Disease (VWD)	Elizabeth Clearfield	Received

PP-323	Mapping the Journey of Caregivers and Patients with Hemophilia A and B in Brazil	Indianara Galhardo	Received

PP-324	Parental Experience of Hemophilia Diagnosis Disclosure in Morocco :A Mixed-Methods Study on Communicational Quality and Psychosocial Impact	Mohamed El khorassani	Received

PP-325	Quality of life assessment in parents of infants with severe hemophilia A without inhibitors after emicizumab prophylaxis	Canan Albayrak	Received

PP-326	Empowering Movement in Hemophilia: A Medically Supervised Trekking Experience	Carlos Kolker	Received

PP-327	Mapping the Journey of Caregivers and Patients Under 6 Years Old with Hemophilia A in Brazil	Mariana Battazza	Received

PP-329	Impact of Hemophilia on Quality of Life and Self-Esteem in Adolescents and Young Adults in South India	Ferose Pallimanhayalil	Received

PP-331	Evaluation of the Quality of Life of Hemophiliac Patients Under Prophylactic Treatment in Cameroon	Toong Youttananukorn	Received

PP-332	Assessment of Joint Arthropathy by FISH and Pain Scoring in Hemophilia Patients: Experience from Pakistan	Munira Borhany	Received

PP-333	Emicizumab Prophylaxis and Its Impact on Bleeding Control, Joint Health, and Psychosocial Well-Being in Hemophilia A	Ayisha Imran	Received

PO-334	Satisfaction Towards A Multidisciplinary Service on Haemophilia Care	YI JING LEE	Received

PO-337	Increasing Patient and Family Knowledge Regarding the Joint Health of Hemophilia Patients: Educational Intervention at Hemophilia Treatment Center Ulin General Hospital, Banjarmasin, Indonesia	Ratih Kumala Sari	Received

PO-339	Impact of Genetic Counseling on Prevention of Factor VII Deficiency in a family from Pakistan.	Lubna Zafar	Received

PO-342	Assessment of Quality of Life in People with Hemophilia on Coagulation Factor Prophylaxis in Brazil	Ricardo Mesquita Camelo	Received

PP-344	Factor XIII Deficiency: Clinical features and Management Approaches from a Specialized Adult Haemophilia Treatment Centre	Kara Cordiner	Received

PP-346	Hereditary Severe Factor X Deficiency in Childhood: Single Centre Experience at Evelina London Children´s Hospital	Jayanthi Alamelu	Received

PP-347	A Sticky Situation: An Illustrated Review of Glanzmann´s Thrombasthenia	Shanthi Hegde	Received

PP-349	Development of A Global Registry: The Glanzmann Thrombasthenia Real-World Insights Research Study	Amy Owen-Wyard	Received

PP-351	Acquired Hemophilia A in a Resource-Limited Setting: Demographic Profile and Real-World Outcomes From a Multi-Centre Retrospective Study	Rema Ganapathi	Received

PP-352	Susoctocog Alfa for Bleeding Control in High-Titer Acquired Hemophilia A: A Case Series of Four Patients	JAE JOON HAN	Received

PP-353	Acquired deficiency of vitamin K dependent factors: an alarming increase in cases. Experience in Banco Municipal de Sangre DC, Caracas	Apsara Boadas	Received

PP-354	Rare Bleeding diosrders - Our experience	Sitalakshmi Subramanian	Received

PO-356	A Challenging Surgery In a Child with Inherited FVII Deficiency and a Huge Nasopharyngeal Angiofibroma	Aysegul Unuvar	Received

PO-358	Prophylaxis for Inherited Deficiency of Factor X: A Systematic Review	Ricardo Mesquita Camelo	Received

PO-359	Proposed Diagnostic Algorithm for Rare Bleeding Disorders	Veronica Arrieta	Received

PP-360	Optimization of Clotting Factor Concentrates Use During Circumcision in People with Hemophilia: A Retrospective Analysis from a Low-Middle Income Country.	Shigy Francis	Received

PP-361	Perioperative Management With Lonoctocog Alfa (Afstyla) in Hemophilia A: Real-World Surgical Experience	Olga Benítez Hidalgo	Received

PP-362	Surgical Management in Hemophilia Patients Receiving Efmoroctocog Alfa	Goksel Leblebisatan	Received

PP-363	Expanding Surgical Boundaries in Severe Hemophilia A: Successful Orthognathic Correction Using PK-Guided Extended Half-Life FVIII in a Middle-Income Country	Eileen Viviana Fonseca	Received

PO-365	Perioperative Management and Surgical Outcomes in Patients With Inherited Bleeding Disorders in a Public Sector Hospital: The Pakistan Institute of Medical Sciences Experience	Farwa Sijjeel	Received

PO-366	Intussusception Secondary to Meckel´s Diverticulitis: A Rare and Life-Threatening Complication in an Infant with Hemophilia A	Serap Karaman	Received

PP-370	Pilot Study Exploring the Lived Experiences of Adolescents and Adults with von Willebrand Disease Treated with VGA039 and Their Families in the VIVID-3 Phase 1/2 Clinical Study	Kristen Jaworski	Received

PO-371	Low-Dose Emicizumab Prophylaxis in Severe Hemophilia A: A Trial in Progress Evaluating Feasibility and Accessibility in a Resource-Limited Setting	Ayisha Imran	Received

MP-372	Plasma-Derived VWF/FVIII Prophylaxis in Children Under 6 With VWD: First Results From WIL-33	Akshat Jain	Received

MP-373	Pregnancy Outcomes in Women with Von Willebrand Disease: A Statewide Cohort Study	Ming Y Lim	Received

MP-374	Recombinant von Willebrand Factor, Vonicog alfa: United Kingdom experience of its use in children under 18 years of age	Jayanthi Alamelu	Received

MP-375	Clinical Spectrum, Subtype Distribution, And Treatment Outcomes In Von Willebrand Disease: A Prospective Study From A Hemophilia Treatment Center In Pakistan	Munira Borhany	Received

PP-379	Expanding the PIVOT-vWD Programme: An International Patient-Driven Study to Capture the Impact, Voice, and Outcomes of von Willebrand Disease	George Morgan	Received

PP-380	Pregnancy Outcomes and Hemostatic Management in Women with Von Willebrand Disease: A Single-Center Experience	Chin Sheng Ting	Received

PP-382	Successfully Searching to See Type 1C von Willebrand Disease	Karen Sims	Received

PP-383	Bridging the Diagnostic Gap: Development and Validation of a Localized Screening Tool for Von Willebrand Disease in a Taiwanese Cohort	Chun-Hui Chiao	Received

PP-384	Von Willebrand Disease and prophylactic treatment	Ons Ghali	Received

PP-385	Managing Type 3 von Willebrand Disease Complicated by Anti-VWF Alloantibodies: A Therapeutic Challenge	Wafa Chenbah	Received

MP-386	Global Utilisation and Impact of VWDtest.com: A Multilingual Digital Platform to Improve Awareness and Early Identification of von Willebrand Disease	Fernando F. Corrales-Medina	Received

MP-388	They´re Missing: The Underrepresentation of Women and Girls with Hemophilia in the WBDR	Pamela Dakik	Received

MP-389	Demographic and Socioeconomic Characteristics of Females in the Community Voices in Research Registry	Paxton G. Mills	Received

MP-390	Assessment of joint health using HEAD-US scores among asymptomatic mothers of hemophilia/Familial Mediterranean fever patients and women with Type 3 von Willebrand disease	ZÜHRE KAYA	Received

MP-391	Strengthening Diagnostics and Patient Care for Women and Girls With Bleeding Disorders Through International Capacity-Building and Twinning Programme	Bitty Kurian	Received

MP-394	Bleeding Profile and Health Related Quality of Life among Females Living with Bleeding Disorders: A Single-Centre Observational study.	Rema Ganapathi	Received

MP-395	Inherited Bleeding Disorders in Women: A 15 year cohort review from a single comprehensive center in Australia	Kara Cordiner	Received

MP-396	Females Affected by Hemophilia A; Data From the U.S. 8CHECK Program	Barbara Konkle	Received

PP-397	Perceived Health Status in Women with haemophilia and Carriers	Carla Daffunchio	Received

PP-398	Improving Diagnosis and Treatment of Women with VWD in Pakistan: A Two Phase Analysis Using WBDR Data and Shared Decision Making Tools	Tahira Zafar	Received

PP-399	Advancing Global Data Collection for Women with Bleeding Disorders: Early Insights from the PROBE WBD Module	Dawn Rotellini	Received

PP-400	Unraveling Pathogenic Variants in the F8 Gene in Females with Mild Hemophilia A and Asymptomatic Carriers: Detecting Compound and Double Heterozygous	Yasser Vega	Received

PP-403	Cross-cultural Adaptation and Reliability of the Self-administered ISTH Bleeding Assessment Tool	Sowmya Nayak	Received

MP-405	Bleeding Profiles and ISTH-BAT Assessment in Women and Girls with Hemophilia: Insight from an Indonesian Referral Center	Fitri Primacakti	Received

PP-409	Opportunities at Birth: Postpartum Hemorrhage as an Indicator for Early Hemophilia Screening in Low- and Middle-Income Countries	Maureen Kiio	Received

PP-410	Becoming Stronger in the Bleed: A Phenomenological Case of a Young Pakistani Nurse Living With Severe Von Willebrand Disease Type 3	wajiha javaid	Received

PO-413	Gendered Marital Challenges for Girls with von Willebrand Disease in Pakistan	wajiha javaid	Received

PP-417	Surgical synovectomy in moderate to severe Haemophilic arthropathy - a systematic review	Adam Hussain	Received

PP-420	Wiskott-Aldrich Syndrome Case Series and Novel Whole Blood Exchange Transfusion	Walter Kelley	Received

PP-421	Successful Utilisation of Low Dose Emicizumab in the Bleeding Management of Acquired Haemophilia; A Single Center Experience	Veena Selvaratnam	Received

PP-422	Microarchitectural Bone Deterioration Despite Preserved Bone Mineral Density in Persons with Hemophilia A	Prisha Nankana	Received

PP-423	Hemophilia treatment and Joint Health: A Colombian Hemophilia Cohort Study	Jose Santacruz-Arias	Received

PP-425	Diagnostic Reassessment of a Congenital Bleeding Disorder From Suspected Factor X Deficiency to von Willebrand Disease	Elen Avetisyan	Received

PP-426	Access to Care, Registry Quality, and Socioeconomic Barriers among People with Hemophilia in Uttar Pradesh, India: A Mixed-Methods Evaluation across Eight Treatment Centers	Prisha Nankana	Received

PP-428	Bridging the Gap: Enhancing Pediatric to Adult Bleeding Disorder Care Transitions with Multidisciplinary SmartPhrases	Denise Lowery	Received

PP-429	Severe Inhibitor Hemophilia A With Refractory Gastrointestinal Bleeding, Massive Transfusion Requirement, and Multisystem Complications: A Case Report	Anna Stepanyan	Received

PP-430	A novel chemiluminescent microfluidic thrombin generation assay detects in vivo aPCC effects with assay-specific sensitivity to accumulated prothrombin levels	Aernoud Bavinck	Received

PO-433	Perception and Practice of Shared Decision-Making in Hemophilia Care in China: Interim Results from a Multicenter Survey	Karina Chin Po Hsu	Received

PP-434	Spectrum of F8 Gene Variants in a Multi-Ethnic Cohort of Malaysian Haemophilia A Patients	Yuslina Mat Yusoff	Received

PP-436	Epidemiological Landscape and Gender Equity in a Colombian Coagulation Disorder Program	Jose Santacruz-Arias	Received

PP-437	Bolar Provisions as a Legal Mechanism for Health Equity in Hemophilia: A Case Study on Emicizumab	Tirsa M. Carcamo Bonilla	Received

PO-440	Impact of Joint Health on Quality of Life in Haemophilia Patients Receiving On-Demand Therapy in Indonesia	Muhammad Hakim Abyantoro	Received

PO-441	Strengthening Hemophilia Care Through Patient Advocacy and Community-Led Initiatives in Khyber Pakhtunkhwa, KP, Pakistan	Syed Shabistan	Received

PO-442	Low dose subcutaneous protein C concentrates in a Child with homozygous protein C deficiency	Yee Yee Yap	Received

PO-443	Circumcision in Three Boys With Severe Haemophilia A Without Inhibitors Using Standard Factor VIII Replacement: A Case Series	Jihane Layla Azzi	Received

PO-444	Bloodless arthroplasty surgery in patients with bleeding disorders	Yee Yee Yap	Received

PO-445	Surgical Intervention in Von Willebrand Disease: A Single Center Experience	MEHMET CAN UGUR	Received

WFH 2026 World Congress

April 19-22, 2026 Kuala Lumpur

Help Line

Homepage

Personal Area

Search and consult posters online
in an exclusive section
for each poster

ACTIVE FROM 05/04/2026 TO 19/04/2027

Poster
Gallery

Upload
Poster

Featured Poster

Vote poster

Poster Discussion
Forum



		Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.

About us

Terms and Conditions